Viewing Study NCT01589861


Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2026-01-02 @ 9:23 AM
Study NCT ID: NCT01589861
Status: SUSPENDED
Last Update Posted: 2017-03-28
First Post: 2012-03-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
Sponsor:
Organization: